PN HESI Pharmacology Exam Prep Document | 2026/2027
Edition | 200 Verified Questions - 162 Questions with Answers
PN HESI Pharmacology Exam 2026-162 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive review document is meticulously designed for nursing students preparing for the
PN HESI Pharmacology exam. It contains 200 verified questions with correct answers and detailed
rationales, covering all major pharmacological concepts and drug classifications. The content is aligned
with the latest Evolve HESI PN guidelines, ensuring that students are studying the most current and
relevant material. Each question is crafted to reflect the format and difficulty of the actual exam,
providing an authentic practice experience.
Key Features:
Pharmacological Principles and Nursing Implications
Drug Classifications: Analgesics, Anti-inflammatories, and Anesthetics
Cardiovascular and Renal Pharmacology
Endocrine and Metabolic Pharmacology
Neurological and Psychiatric Pharmacology
Respiratory and Gastrointestinal Pharmacology
Antimicrobial and Anti-infective Agents
Oncological and Immunological Agents
Maternal, Pediatric, and Geriatric Pharmacology
Complementary and Alternative Therapies
Pharmacokinetics and Pharmacodynamics
Medication Administration and Safety
Dosage Calculations and Conversions
Legal and Ethical Considerations in Pharmacology
Patient Education and Health Promotion
Drug Interactions and Adverse Effects
Intravenous Therapy and Fluid Balance
Emergency and Critical Care Medications
Updates for 2026:
- Updated to reflect the latest 2026-2027 HESI PN test plan and guidelines
- Incorporated new FDA-approved medications and withdrawn drugs
- Enhanced rationales to include evidence-based practice and current clinical guidelines
- Revised dosage calculation questions to align with updated safety standards
- Added more questions on pharmacological management of chronic diseases
Abstract:
This exam preparation document offers a rigorous and comprehensive review of pharmacology for practical
nursing students. It encompasses 200 meticulously selected questions that mirror the content and cognitive level of
the PN HESI Pharmacology exam. The document is organized to facilitate systematic study, covering fundamental
principles, drug classifications, and clinical applications. Each question is accompanied by a correct answer and a
detailed rationale that explains the underlying pharmacological concepts and clinical reasoning. The content is
updated to reflect the 2026-2027 academic year and the latest Evolve HESI PN guidelines, ensuring that students
are well-prepared for the exam. This resource is an essential tool for achieving a high score and demonstrating
Page 1
,competency in pharmacology.
Keywords:
PN HESI Pharmacology, Exam Review, 200 Questions, Rationales, 2026-2027, Evolve HESI PN, Nursing
Pharmacology, Test Bank
Answer Format:
Each question is presented in a multiple-choice format, followed by the correct answer and a comprehensive
rationale explaining why it is correct and why the other options are incorrect. The rationales are detailed,
referencing pharmacological principles, drug interactions, and clinical considerations to enhance understanding and
retention.
Compliance Checklist:
Aligned with the latest PN HESI Pharmacology test plan
200 verified questions with correct answers and rationales
Updated for the 2026-2027 academic year
Covers all major content areas of the PN HESI Pharmacology exam
Includes dosage calculation and medication safety questions
Suitable for self-assessment and exam preparation
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacological Principles 1-20 Pharmacokinetics, Pharmacodynamics, Drug 10%
Interactions, Adverse Effects
Analgesics and 21-40 Opioids, NSAIDs, Acetaminophen, 10%
Anti-inflammatories Adjuvant Analgesics
Cardiovascular and Renal 41-70 Antihypertensives, Diuretics, 15%
Anticoagulants, Antiarrhythmics
Endocrine and Metabolic 71-90 Insulin, Oral Hypoglycemics, Thyroid 10%
Hormones, Corticosteroids
Neurological and Psychiatric 91-110 Anticonvulsants, Antidepressants, 10%
Antipsychotics, Anxiolytics
Respiratory and Gastrointestinal 111-130 Bronchodilators, Antacids, Antiemetics, 10%
Laxatives
Antimicrobials 131-150 Antibiotics, Antivirals, Antifungals, 10%
Antituberculars
Oncological and Immunological 151-160 Chemotherapy, Immunosuppressants, 5%
Monoclonal Antibodies
Special Populations 161-170 Pediatric, Geriatric, Pregnancy and Lactation 5%
Medication Administration and 171-180 Routes, Calculations, Errors, Rights of 5%
Safety Administration
Dosage Calculations 181-190 Oral, Parenteral, IV Flow Rates, Pediatric 5%
Doses
Legal and Ethical Issues 191-200 Controlled Substances, Prescription 5%
Regulations, Patient Rights
Page 2
,Q1. A patient on chronic warfarin therapy is started on metronidazole for an
anaerobic infection. Three days later, the INR is 5.2. What is the most plausible
mechanism for this interaction?
A. Metronidazole displaces warfarin from protein-binding sites, increasing free drug
concentration.
B. Metronidazole inhibits CYP2C9, decreasing warfarin metabolism and increasing its
anticoagulant effect.
C. Metronidazole reduces vitamin K absorption from the gut, leading to enhanced
warfarin activity.
D. Metronidazole increases warfarin renal clearance, leading to a compensatory
increase in INR.
Correct Answer: B. Metronidazole inhibits CYP2C9, decreasing warfarin metabolism
and increasing its anticoagulant effect.
Rationale: Metronidazole is a potent inhibitor of CYP2C9, the enzyme responsible for
metabolizing the S-enantiomer of warfarin. Inhibition leads to elevated warfarin levels and
increased INR. Protein-binding displacement is a minor and transient interaction for
warfarin, and metronidazole does not significantly affect vitamin K absorption or renal
clearance of warfarin.
Why Wrong:
A - Displacement from protein binding is a transient and clinically insignificant
mechanism for warfarin interactions.
C - Metronidazole does not interfere with vitamin K absorption; this is more
characteristic of antibiotics that alter gut flora (e.g., cephalosporins).
D - Warfarin is metabolized in the liver, not renally cleared; metronidazole does not
increase its elimination.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th ed., Ch. 60.
Q2. A patient is receiving gentamicin IV for a serious Pseudomonas infection. Which
assessment finding would warrant immediate notification of the healthcare provider
due to the highest risk of irreversible toxicity?
A. Serum creatinine increase from 0.8 to 1.2 mg/dL over 48 hours.
B. Tinnitus and a feeling of fullness in the ears.
C. Urine output of 20 mL/hour for two consecutive hours.
D. Serum gentamicin trough level of 2.5 mcg/mL.
Correct Answer: B. Tinnitus and a feeling of fullness in the ears.
Rationale: Tinnitus and aural fullness are early signs of cochlear toxicity, which can
progress to permanent hearing loss even after drug discontinuation. Nephrotoxicity
(elevated creatinine, oliguria) is often reversible if detected early, and trough levels >2
mcg/mL increase nephrotoxicity risk but are not immediately irreversible. The priority is
Page 3
, to stop the drug to prevent permanent ototoxicity.
Why Wrong:
A - A creatinine increase is a sign of nephrotoxicity, but it is often reversible with
early intervention.
C - Oliguria indicates renal impairment, but it is not as immediately irreversible as
ototoxicity.
D - An elevated trough level increases risk of toxicity but does not itself indicate
irreversible damage.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th ed., Ch. 82.
Q3. A patient with type 2 diabetes is prescribed metformin. Which instruction is
essential for the nurse to include in patient teaching to prevent a life-threatening
adverse effect?
A. Take the medication with meals to reduce gastrointestinal upset.
B. Report any episodes of hypoglycemia immediately.
C. Discontinue the medication temporarily during periods of vomiting or diarrhea.
D. Avoid alcohol consumption while taking this medication.
Correct Answer: C. Discontinue the medication temporarily during periods of
vomiting or diarrhea.
Rationale: Metformin carries a risk of lactic acidosis, especially in patients with renal
impairment or conditions causing tissue hypoxia, such as dehydration, vomiting, or
diarrhea. The medication should be temporarily withheld during acute illness with
dehydration to prevent lactic acidosis. Alcohol is a minor risk factor, but the most critical
instruction is to stop the drug during dehydrating illness.
Why Wrong:
A - Taking with meals reduces GI upset but is not essential to prevent a
life-threatening effect.
B - Metformin rarely causes hypoglycemia; this is not the primary safety concern.
D - Alcohol increases the risk of lactic acidosis but is not as immediately critical as
acute dehydration.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th ed., Ch. 45.
Q4. A nurse is reviewing a prescription for enoxaparin. Which finding indicates a
need to question the prescription?
A. The patient has a platelet count of 150,000/mm³.
B. The patient is receiving warfarin concurrently.
C. The patient has a creatinine clearance of 25 mL/min.
D. The patient weighs 80 kg and is receiving 1 mg/kg every 12 hours.
Correct Answer: C. The patient has a creatinine clearance of 25 mL/min.
Page 4
Edition | 200 Verified Questions - 162 Questions with Answers
PN HESI Pharmacology Exam 2026-162 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive review document is meticulously designed for nursing students preparing for the
PN HESI Pharmacology exam. It contains 200 verified questions with correct answers and detailed
rationales, covering all major pharmacological concepts and drug classifications. The content is aligned
with the latest Evolve HESI PN guidelines, ensuring that students are studying the most current and
relevant material. Each question is crafted to reflect the format and difficulty of the actual exam,
providing an authentic practice experience.
Key Features:
Pharmacological Principles and Nursing Implications
Drug Classifications: Analgesics, Anti-inflammatories, and Anesthetics
Cardiovascular and Renal Pharmacology
Endocrine and Metabolic Pharmacology
Neurological and Psychiatric Pharmacology
Respiratory and Gastrointestinal Pharmacology
Antimicrobial and Anti-infective Agents
Oncological and Immunological Agents
Maternal, Pediatric, and Geriatric Pharmacology
Complementary and Alternative Therapies
Pharmacokinetics and Pharmacodynamics
Medication Administration and Safety
Dosage Calculations and Conversions
Legal and Ethical Considerations in Pharmacology
Patient Education and Health Promotion
Drug Interactions and Adverse Effects
Intravenous Therapy and Fluid Balance
Emergency and Critical Care Medications
Updates for 2026:
- Updated to reflect the latest 2026-2027 HESI PN test plan and guidelines
- Incorporated new FDA-approved medications and withdrawn drugs
- Enhanced rationales to include evidence-based practice and current clinical guidelines
- Revised dosage calculation questions to align with updated safety standards
- Added more questions on pharmacological management of chronic diseases
Abstract:
This exam preparation document offers a rigorous and comprehensive review of pharmacology for practical
nursing students. It encompasses 200 meticulously selected questions that mirror the content and cognitive level of
the PN HESI Pharmacology exam. The document is organized to facilitate systematic study, covering fundamental
principles, drug classifications, and clinical applications. Each question is accompanied by a correct answer and a
detailed rationale that explains the underlying pharmacological concepts and clinical reasoning. The content is
updated to reflect the 2026-2027 academic year and the latest Evolve HESI PN guidelines, ensuring that students
are well-prepared for the exam. This resource is an essential tool for achieving a high score and demonstrating
Page 1
,competency in pharmacology.
Keywords:
PN HESI Pharmacology, Exam Review, 200 Questions, Rationales, 2026-2027, Evolve HESI PN, Nursing
Pharmacology, Test Bank
Answer Format:
Each question is presented in a multiple-choice format, followed by the correct answer and a comprehensive
rationale explaining why it is correct and why the other options are incorrect. The rationales are detailed,
referencing pharmacological principles, drug interactions, and clinical considerations to enhance understanding and
retention.
Compliance Checklist:
Aligned with the latest PN HESI Pharmacology test plan
200 verified questions with correct answers and rationales
Updated for the 2026-2027 academic year
Covers all major content areas of the PN HESI Pharmacology exam
Includes dosage calculation and medication safety questions
Suitable for self-assessment and exam preparation
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacological Principles 1-20 Pharmacokinetics, Pharmacodynamics, Drug 10%
Interactions, Adverse Effects
Analgesics and 21-40 Opioids, NSAIDs, Acetaminophen, 10%
Anti-inflammatories Adjuvant Analgesics
Cardiovascular and Renal 41-70 Antihypertensives, Diuretics, 15%
Anticoagulants, Antiarrhythmics
Endocrine and Metabolic 71-90 Insulin, Oral Hypoglycemics, Thyroid 10%
Hormones, Corticosteroids
Neurological and Psychiatric 91-110 Anticonvulsants, Antidepressants, 10%
Antipsychotics, Anxiolytics
Respiratory and Gastrointestinal 111-130 Bronchodilators, Antacids, Antiemetics, 10%
Laxatives
Antimicrobials 131-150 Antibiotics, Antivirals, Antifungals, 10%
Antituberculars
Oncological and Immunological 151-160 Chemotherapy, Immunosuppressants, 5%
Monoclonal Antibodies
Special Populations 161-170 Pediatric, Geriatric, Pregnancy and Lactation 5%
Medication Administration and 171-180 Routes, Calculations, Errors, Rights of 5%
Safety Administration
Dosage Calculations 181-190 Oral, Parenteral, IV Flow Rates, Pediatric 5%
Doses
Legal and Ethical Issues 191-200 Controlled Substances, Prescription 5%
Regulations, Patient Rights
Page 2
,Q1. A patient on chronic warfarin therapy is started on metronidazole for an
anaerobic infection. Three days later, the INR is 5.2. What is the most plausible
mechanism for this interaction?
A. Metronidazole displaces warfarin from protein-binding sites, increasing free drug
concentration.
B. Metronidazole inhibits CYP2C9, decreasing warfarin metabolism and increasing its
anticoagulant effect.
C. Metronidazole reduces vitamin K absorption from the gut, leading to enhanced
warfarin activity.
D. Metronidazole increases warfarin renal clearance, leading to a compensatory
increase in INR.
Correct Answer: B. Metronidazole inhibits CYP2C9, decreasing warfarin metabolism
and increasing its anticoagulant effect.
Rationale: Metronidazole is a potent inhibitor of CYP2C9, the enzyme responsible for
metabolizing the S-enantiomer of warfarin. Inhibition leads to elevated warfarin levels and
increased INR. Protein-binding displacement is a minor and transient interaction for
warfarin, and metronidazole does not significantly affect vitamin K absorption or renal
clearance of warfarin.
Why Wrong:
A - Displacement from protein binding is a transient and clinically insignificant
mechanism for warfarin interactions.
C - Metronidazole does not interfere with vitamin K absorption; this is more
characteristic of antibiotics that alter gut flora (e.g., cephalosporins).
D - Warfarin is metabolized in the liver, not renally cleared; metronidazole does not
increase its elimination.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th ed., Ch. 60.
Q2. A patient is receiving gentamicin IV for a serious Pseudomonas infection. Which
assessment finding would warrant immediate notification of the healthcare provider
due to the highest risk of irreversible toxicity?
A. Serum creatinine increase from 0.8 to 1.2 mg/dL over 48 hours.
B. Tinnitus and a feeling of fullness in the ears.
C. Urine output of 20 mL/hour for two consecutive hours.
D. Serum gentamicin trough level of 2.5 mcg/mL.
Correct Answer: B. Tinnitus and a feeling of fullness in the ears.
Rationale: Tinnitus and aural fullness are early signs of cochlear toxicity, which can
progress to permanent hearing loss even after drug discontinuation. Nephrotoxicity
(elevated creatinine, oliguria) is often reversible if detected early, and trough levels >2
mcg/mL increase nephrotoxicity risk but are not immediately irreversible. The priority is
Page 3
, to stop the drug to prevent permanent ototoxicity.
Why Wrong:
A - A creatinine increase is a sign of nephrotoxicity, but it is often reversible with
early intervention.
C - Oliguria indicates renal impairment, but it is not as immediately irreversible as
ototoxicity.
D - An elevated trough level increases risk of toxicity but does not itself indicate
irreversible damage.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th ed., Ch. 82.
Q3. A patient with type 2 diabetes is prescribed metformin. Which instruction is
essential for the nurse to include in patient teaching to prevent a life-threatening
adverse effect?
A. Take the medication with meals to reduce gastrointestinal upset.
B. Report any episodes of hypoglycemia immediately.
C. Discontinue the medication temporarily during periods of vomiting or diarrhea.
D. Avoid alcohol consumption while taking this medication.
Correct Answer: C. Discontinue the medication temporarily during periods of
vomiting or diarrhea.
Rationale: Metformin carries a risk of lactic acidosis, especially in patients with renal
impairment or conditions causing tissue hypoxia, such as dehydration, vomiting, or
diarrhea. The medication should be temporarily withheld during acute illness with
dehydration to prevent lactic acidosis. Alcohol is a minor risk factor, but the most critical
instruction is to stop the drug during dehydrating illness.
Why Wrong:
A - Taking with meals reduces GI upset but is not essential to prevent a
life-threatening effect.
B - Metformin rarely causes hypoglycemia; this is not the primary safety concern.
D - Alcohol increases the risk of lactic acidosis but is not as immediately critical as
acute dehydration.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th ed., Ch. 45.
Q4. A nurse is reviewing a prescription for enoxaparin. Which finding indicates a
need to question the prescription?
A. The patient has a platelet count of 150,000/mm³.
B. The patient is receiving warfarin concurrently.
C. The patient has a creatinine clearance of 25 mL/min.
D. The patient weighs 80 kg and is receiving 1 mg/kg every 12 hours.
Correct Answer: C. The patient has a creatinine clearance of 25 mL/min.
Page 4
